Governor Maura Healey has recognized genetically targeted technologies as a vital part of the future of medicine during 2026 Medical Genetics Awareness Week. Download the full proclamation as a PDF at the button below. The Commonwealth of Massachusetts A Proclamation Whereas,Over 200,000 children and adults in Massachusetts have intellectual and developmental disabilities; and Whereas,All people […]
Letters & Statements
Statement on Centers for Medicare and Medicaid Services Proposed Rule on Obesity Coverage
December 17, 2024 Washington, DC– The Partnership to Advance Cardiovascular Health applauds the Centers for Medicare and Medicaid Services’ proposal to cover obesity treatments under Medicare and Medicaid. The announcement from CMS would allow a path to coverage to finally treat obesity as a disease, extending care for millions of Americans, saving lives and preventing […]
Non-Medical Switching Poses a Danger to Medicare Patients
Letter to CMS on the need to monitor non-medical switching protocols to protect patient access.
CMS Semaglutide Obesity Coverage
Letter to CMS on the need for obesity treatment coverage.
CMS Semaglutide Coverage Expansion Could Save Millions of Lives, Advocates Say
44 organizations across various disease states support an expansion of semaglutide coverage for Medicare and Medicaid patients.
Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers
Letter to FTC requesting public comments on the business practices of PBMs.